COVID-19 Update - This is to inform you that the Government of India has announced a complete lockdown in India 22nd March 2020 to 3rd May 2020. As a result, our offices will now be closed till 3rd May 2020 and all our employees will be working from home. Office telephones will not be answered, and therefore you are requested to direct all your queries related to manuscript submission, review process, publication etc. at below mentioned details.,, Mob. 8826373757, 8826859373, 9910947804

Print ISSN:-2394-6369

Online ISSN:-2394-6377


Current Issue

Year 2020

Volume: 7 , Issue: 1

Article Access statistics

Viewed: 416

Emailed: 0

PDF Downloaded: 160

International Journal of Clinical Biochemistry and Research

Association of gamma glutamyl transferase with prostate specific antigen levels in patients with prostatic disorders

Full Text PDF Share on Facebook Share on Twitter

Research Article

Author Details : S Rashmi*, Santhi Silambanan, L Shalini

Volume : 6, Issue : 2, Year : 2019

Article Page : 176-181

Suggest article by email


Introduction: Prostate related diseases like prostatitis, Benign Prostatic Hyperplasia (BPH), prostatic carcinoma are observed most commonly in elderly males. Prostatic specific antigen (PSA) is a common biomarker of prostate related disorders but due to various limitations, new biomarkers are in need for prostate diseases diagnosis. Gamma Glutamyl Transferase (GGT) is also known to be synthesised by the prostate gland. In this study we evaluated the role of GGT as a biomarker of prostatic disorders by observing the association of GGT with PSA.
Materials and Methods: This case control study was conducted at Sri Ramachandra Medical college & Research Institute, Sri Ramachandra Institute of Higher Education and Research, Chennai In this study the case group consisted of 38 males aged between 45-90 years with prostate disorders (prostatitis, BPH, Prostatic cancer). The control group consisted of 187 healthy males of age 45-90 years. Patients with high ALP were excluded to rule out hepatobiliary disease. Relevant patient details and laboratory investigations were collected and statistical analysis done.
Results: The correlation coefficient, r value between PSA and GGT in the control group was –0.076 and in the cases group was -0.049. There was no statistically significant difference between the PSA and GGT levels in both the study groups (p value in control group=0.300; p value in cases group=0.769).
Conclusion: From this study we conclude that GGT cannot be used as a prostate diseases biomarker as there was not much statistical significant difference between the PSA and GGT values among both the controls and cases group.

Keywords: Prostate disorders, Benign prostatic hyperplasia (BPH), Prostatic cancer, Gamma glutamyl transferase, Prostate specific antigen.

Doi : 10.18231/j.ijcbr.2019.041

How to cite : Rashmi S, Silambanan S, Shalini L, Association of gamma glutamyl transferase with prostate specific antigen levels in patients with prostatic disorders. Int J Clin Biochem Res 2019;6(2):176-181

Copyright © 2019 by author(s) and Int J Clin Biochem Res. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0) (